12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-09), Inotiv's 12-1 Month Momentum % is 16.16%.
The industry rank for Inotiv's 12-1 Month Momentum % or its related term are showing as below:
NOTV's 12-1 Month Momentum % is ranked better than 82.05% of 234
companies
in the Medical Diagnostics & Research industry
Industry Median: -20.415
vs NOTV: 16.16
Competitive Comparison of Inotiv's 12-1 Month Momentum %
For the Diagnostics & Research subindustry, Inotiv's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inotiv's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Inotiv's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Inotiv 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Inotiv's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NOTV has been successfully added to your